Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial.
about
Stem cell therapy for chronic ischaemic heart disease and congestive heart failureStem cell therapy for chronic ischaemic heart disease and congestive heart failure.Injectable hydrogel as stem cell scaffolds from the thermosensitive terpolymer of NIPAAm/AAc/HEMAPCLBone marrow derivation of interstitial cells of cajal in small intestine following intestinal injury.Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells.An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial.The hematopoietic system in the context of regenerative medicine.Stem cell therapy for heart diseases.The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine.A new heart: somatic stem cells and myocardial regeneration.Cell delivery routes for stem cell therapy to the heart: current and future approaches.New cell therapies in cardiology.Magnetic manipulation of bacterial magnetic nanoparticle-loaded neurospheres.Direct comparison of progenitor cells derived from adipose, muscle, and bone marrow from wild-type or craniosynostotic rabbits.Lin- cells mediate tissue repair by regulating MCP-1/CCL-2.Increases in plasma Tβ4 after intracardiac cell therapy in chronic ischemic heart failure is associated with symptomatic improvement.Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study.Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease.The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.The clinician-scientist: professional dynamics in clinical stem cell research
P2860
Q24194988-D4485F6A-45D9-4224-8987-B8473F2314B0Q30239945-2889F13D-BD74-4D7A-9FC5-BD124EDDAD04Q30571628-73F45BD8-2025-4091-BBCF-E942BF3C27CAQ33789020-2BFFF026-FBC7-474C-B7AA-B0D52A2EA1DAQ34009778-D0CB3F77-3002-427B-9254-1094A2654FEFQ36176870-78D4762D-D8C8-470D-A389-7B4387A319CFQ36627127-CFB8CE7F-6349-4EC8-8C81-1062F62CDB95Q37877423-51A41AA3-9574-4891-8B50-1529F32CB6DEQ37910044-533BFC14-D8AE-4620-B292-0F2D84A4D7FAQ37996356-2F9B8FF4-A70E-409B-8DDE-DD1651CB6D8FQ38014708-6C7D50EB-13A7-4E35-AADC-4B843DFB7ABAQ38048838-06A658F0-C870-48C4-97C2-41C0180FE078Q39014531-018FCCA2-10B4-4E43-9307-4A0DD18C681BQ41612445-1A0BB307-EE99-4253-B97A-B8D667948E66Q42416696-A54CCEE2-1CA9-4035-ACCE-31552AF28F24Q48154865-0CA66CE7-E376-4E1E-907D-2DD0DA3A482AQ48712903-3A67D2FD-4085-449A-8E7E-1134395C8F77Q50677671-AC4911C0-9733-4570-8A26-7EC13DF18B68Q55415942-AC811A0A-EBBB-4F95-A9F7-B6B4CBD09666Q58610264-D3CFAB6A-4D5B-4DFC-BEEB-87BDFDB82054
P2860
Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Autologous bone marrow-derived ...... failure: REGENERATE-IHD trial.
@en
Autologous bone marrow-derived ...... failure: REGENERATE-IHD trial.
@nl
type
label
Autologous bone marrow-derived ...... failure: REGENERATE-IHD trial.
@en
Autologous bone marrow-derived ...... failure: REGENERATE-IHD trial.
@nl
prefLabel
Autologous bone marrow-derived ...... failure: REGENERATE-IHD trial.
@en
Autologous bone marrow-derived ...... failure: REGENERATE-IHD trial.
@nl
P2860
P356
P1476
Autologous bone marrow-derived ...... failure: REGENERATE-IHD trial.
@en
P2093
Anthony Mathur
P2860
P304
P356
10.2217/17460751.4.1.119
P577
2009-01-01T00:00:00Z